Read the original: Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
Read the original: Myriad Genetics Names George Daneker Jr., MD, as President and Chief Clinical Officer of Oncology
Global Stem Cell Therapy Industry Outlook to 2028, Driven by Therapeutic Innovations and Clinical Advancements ... Yahoo Finance
Out-of-this-world study will test how stem cells function in space YP
Exploring pharmacological, non-pharmacological, and stem cell therapies for treatment of autism spectrum disorders News-Medical.Net
Read more: InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
Read the rest here: Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
Read the rest here: Ocular Therapeutix™ Announces FDA Agreement to Amend Special Protocol Assessment (SPA) for Pivotal Clinical Trial of AXPAXLI™ in Wet AMD
Read the original here: Kronos Bio Implements New Leadership Structure to Drive Pipeline Advancement
Read the original post: Windtree Eliminates $15 Million Contingent Liability to Deerfield Management Company
See the original post: Veru to Report Fiscal 2024 First Quarter Financial Results on February 8, 2024
Recent Comments